BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16338393)

  • 1. High-throughput screening for inhibitors of the e3 ubiquitin ligase APC.
    Huang J; Sheung J; Dong G; Coquilla C; Daniel-Issakani S; Payan DG
    Methods Enzymol; 2005; 399():740-54. PubMed ID: 16338393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APC2 Cullin protein and APC11 RING protein comprise the minimal ubiquitin ligase module of the anaphase-promoting complex.
    Tang Z; Li B; Bharadwaj R; Zhu H; Ozkan E; Hakala K; Deisenhofer J; Yu H
    Mol Biol Cell; 2001 Dec; 12(12):3839-51. PubMed ID: 11739784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Budding yeast RSI1/APC2, a novel gene necessary for initiation of anaphase, encodes an APC subunit.
    Kramer KM; Fesquet D; Johnson AL; Johnston LH
    EMBO J; 1998 Jan; 17(2):498-506. PubMed ID: 9430641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of approaches for screening for ubiquitin ligase inhibitors.
    Sun Y
    Methods Enzymol; 2005; 399():654-63. PubMed ID: 16338387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel approach for characterizing ubiquitin E3 ligase function.
    Marblestone JG; Suresh Kumar KG; Eddins MJ; Leach CA; Sterner DE; Mattern MR; Nicholson B
    J Biomol Screen; 2010 Dec; 15(10):1220-8. PubMed ID: 20864734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative assays of Mdm2 ubiquitin ligase activity and other ubiquitin-utilizing enzymes for inhibitor discovery.
    Auger KR; Copeland RA; Lai Z
    Methods Enzymol; 2005; 399():701-17. PubMed ID: 16338390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The RING-H2-finger protein APC11 as a target of hydrogen peroxide.
    Chang TS; Jeong W; Lee DY; Cho CS; Rhee SG
    Free Radic Biol Med; 2004 Aug; 37(4):521-30. PubMed ID: 15256223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The APC/C E3 ligase remains active in most post-mitotic Arabidopsis cells and is required for proper vasculature development and organization.
    Marrocco K; Thomann A; Parmentier Y; Genschik P; Criqui MC
    Development; 2009 May; 136(9):1475-85. PubMed ID: 19336465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Throughput Screening of HECT E3 Ubiquitin Ligases Using UbFluor.
    Foote PK; Krist DT; Statsyuk AV
    Curr Protoc Chem Biol; 2017 Sep; 9(3):174-195. PubMed ID: 28910856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cell-based high-throughput screening method based on a ubiquitin-reference technique for identifying modulators of E3 ligases.
    Tian M; Zeng T; Liu M; Han S; Lin H; Lin Q; Li L; Jiang T; Li G; Lin H; Zhang T; Kang Q; Deng X; Wang HR
    J Biol Chem; 2019 Feb; 294(8):2880-2891. PubMed ID: 30587574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UV-induced degradation of securin is mediated by SKP1-CUL1-beta TrCP E3 ubiquitin ligase.
    Limón-Mortés MC; Mora-Santos M; Espina A; Pintor-Toro JA; López-Román A; Tortolero M; Romero F
    J Cell Sci; 2008 Jun; 121(11):1825-31. PubMed ID: 18460583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Doc1 subunit is a processivity factor for the anaphase-promoting complex.
    Carroll CW; Morgan DO
    Nat Cell Biol; 2002 Nov; 4(11):880-7. PubMed ID: 12402045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods to measure ubiquitin-dependent proteolysis mediated by the anaphase-promoting complex.
    Kraft C; Gmachl M; Peters JM
    Methods; 2006 Jan; 38(1):39-51. PubMed ID: 16343932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of ubiquitin ligase substrates by in vitro expression cloning.
    Ayad NG; Rankin S; Ooi D; Rape M; Kirschner MW
    Methods Enzymol; 2005; 399():404-14. PubMed ID: 16338372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assay for ubiquitin ligase activity: high-throughput screen for inhibitors of HDM2.
    Davydov IV; Woods D; Safiran YJ; Oberoi P; Fearnhead HO; Fang S; Jensen JP; Weissman AM; Kenten JH; Vousden KH
    J Biomol Screen; 2004 Dec; 9(8):695-703. PubMed ID: 15634796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The MALDI-TOF E2/E3 Ligase Assay as Universal Tool for Drug Discovery in the Ubiquitin Pathway.
    De Cesare V; Johnson C; Barlow V; Hastie J; Knebel A; Trost M
    Cell Chem Biol; 2018 Sep; 25(9):1117-1127.e4. PubMed ID: 30017913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subunits and substrates of the anaphase-promoting complex.
    Peters JM
    Exp Cell Res; 1999 May; 248(2):339-49. PubMed ID: 10222126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Generic Platform for Cellular Screening Against Ubiquitin Ligases.
    Maculins T; Carter N; Dorval T; Hudson K; Nissink JW; Hay RT; Alwan H
    Sci Rep; 2016 Jan; 6():18940. PubMed ID: 26743172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anaphase-promoting complex: new subunits and regulators.
    Page AM; Hieter P
    Annu Rev Biochem; 1999; 68():583-609. PubMed ID: 10872461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragment-Based Covalent Ligand Screening Enables Rapid Discovery of Inhibitors for the RBR E3 Ubiquitin Ligase HOIP.
    Johansson H; Isabella Tsai YC; Fantom K; Chung CW; Kümper S; Martino L; Thomas DA; Eberl HC; Muelbaier M; House D; Rittinger K
    J Am Chem Soc; 2019 Feb; 141(6):2703-2712. PubMed ID: 30657686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.